Cancer Statistics, 2002

By A. Jemal, Andrea Thomas, Taylor Murray, M. Thun. Ca, 2002

3,069 citations recorded by the source corpus.

Every year the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival, using National Cancer Institute (NCI) incidence and National Center for Health Statistics (NCHS) mortality data. Incidence and death rates are age adjusted to the 1970 US standard population. It is estimated that 1,284,900 new cases of cancer will be diagnosed and 555,500 people will die from cancer in the United States in the year 2002. From 1992 to 1998, cancer death rates declined in males and females, while cancer incidence rates decreased among males and increased slightly among females. Most notably, African‐American men showed the largest decline for both incidence and mortality. Nevertheless, African Americans still carry the highest burden of cancer with later‐stage cancer diagnosis and poorer survival compared with whites. Despite the continued decline in cancer death rates, the total number of recorded cancer deaths in the United States continues to increase slightly due to the aging and expanding population.

Subfields: Cancer Research, Genetics, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/fb3fdaebe4c5a97f7e1136d09ad07f030f3b83f0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Charles M. Perou
2. Scott W. Lowe
3. M. Soengas

Citations in the corpus

• Acute Myeloid Leukemia: Epidemiology and Etiology (2006, neutral): “Figure 3.1 shows agestandardized incidence rates stratified by various countries [ 7 ].”
• Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. (2004, background): “No biomarkers analogous to the estrogen receptor or HER2 in breast cancers, or c-KIT in gastrointestinal stromalfor over 40,000 cases of cancer per year in the US (Jemal et al., 2002; Landis et al., 1999).”
• Apoptosis and melanoma chemoresistance (2003, background): “A simple look at the statistics is alarming: the lifetime risk of melanoma continues to increase steadily, reaching one in 75 (Jemal et al., 2002).”